https://youtu.be/bwn8SYpkmv0 At a gala celebration in Toronto on 29 September 2022, NMIN Founding Director Dr. Pieter Cullis was announced as the winner of the 2022 Bloom Burton Award. “We are honoured to recognize Pieter Cullis with the award,” said Jolyon Burton, President of Bloom Burton & Co., a firm dedicated… Read More »Pieter Cullis wins 2022 Bloom Burton Award
L to R: Yulin Mo, Dr. Miffy Cheng and Jerry Leung. NMIN is extremely proud to acknowledge the NMIN trainees who won all three of the Poster Awards granted at Liposome Research Days (LRD) 2022. Yulin Mo (University of Toronto), Dr. Miffy Cheng and Jerry Leung (both at The University… Read More »NMIN trainees win all three poster awards at LRD 2022
The NanoMedicines Innovation Network (NMIN) is pleased to announce the 15 recipients of the its 2022 Masters- and Doctoral-level Graduate Awards. Recipients hail from seven universities in five provinces. The goal of NMIN Graduate Awards is to enable exceptional students to pursue nanomedicine academic research training with Canadian experts. Doctoral… Read More »Meet the winners of NMIN’s 2022 Graduate Awards
Dr. Pieter Cullis continues to accumulate accolades for his life’s work developing liposomal-based technologies as the basis for novel therapeutic approaches to diagnosing, treating, and curing disease. An additional recognition, “for his scientific entrepreneurialism and advancement of life sciences research,” is coming in the form of the Global Impact Award… Read More »Pieter Cullis to receive Global Impact Award from Life Sciences BC
The start-up company SeraGene, spun out of NMIN and co-founded by NMIN research co-leader Dr. Christian Kastrup (UBC), NMIN HQP Amy Wong-Strilchuk, and NMIN’s Founding Scientific Director, Dr. Pieter Cullis, has received a 2022 “Amgen Golden Ticket” at the UBC-based SBME Innovates incubation hub. UBC’s School of Biomedical Engineering (SBME)… Read More »NMIN start-up SeraGene wins Amgen-sponsored incubation support
For their contributions to the development of an mRNA-based COVID vaccine, NMIN’s Founding Scientific Director, Dr. Pieter Cullis (UBC), together with his colleagues Drs Katalin Karikó (University of Szeged) and Drew Weissman (University of Pennsylvania), have been jointly awarded the 2022 Tang Prize in in Biopharmaceutical Science. The prize recognizes… Read More »Dr. Pieter Cullis & colleagues awarded 2022 Tang Prize
The NanoMedicines Innovation Network (NMIN) is pleased to announce the eight recipients of the 2022 NMIN Undergraduate Studentships in NanoMedicines Research awards. The awardees will receive a stipend of $1,500 a month for a maximum of four months between May 2022 and March 2023, to work on a nanomedicines-related research… Read More »2022 NMIN Undergraduate Studentships awarded
The NanoMedicines Innovation Network (NMIN) is pleased to announce eight new recipients of NMIN Advanced Training Certification (ATC). NMIN’s Advanced Training Certification, or ATC, recognizes an individual’s engagement in diverse capacity-building activities offered by NMIN, its partners, and other recognized organizations, where the learning involved goes “above and beyond” the… Read More »Eight new recipients of NMIN’s Advanced Training Certification (ATC) announced
NMIN’s Founding Director, Dr. Pieter Cullis, has been named an Officer of the Order of Canada, in recognition of his contributions to the advancement of biomedical research and drug development, and for his mentorship of the next generation of scientists and entrepreneurs. One of the nation’s highest forms of recognition,… Read More »Dr. Pieter Cullis named an Officer of the Order of Canada
The NanoMedicines Innovation Network (NMIN) is pleased to announce the recipient of its 2021 NMIN Postdoctoral Fellowship in Gene Therapy: Dr. Miffy Hok Yan Cheng. The awardee was selected by the members of NMIN’s Research Management Committee, based on the applicant’s qualifications, as well as the quality of the proposed… Read More »2021 NMIN Postdoctoral Fellowship in Gene Therapy winner announced